{"id":13233,"date":"2020-12-24T00:07:00","date_gmt":"2020-12-24T00:07:00","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/qnostics-develops-sars-cov-2-test-controls\/"},"modified":"2021-01-14T11:42:32","modified_gmt":"2021-01-14T11:42:32","slug":"qnostics-develops-sars-cov-2-test-controls","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/qnostics-develops-sars-cov-2-test-controls\/","title":{"rendered":"Qnostics develops SARS-CoV-2 test controls"},"content":{"rendered":"<p>Qnostics, a world leading manufacturer of QC solutions for molecular infectious disease testing, has developed a range of products designed to support the validation, verification and performance monitoring of molecular assays used in the testing of SARS-CoV-2.<br \/>\nConveniently combining SARS-CoV-2, Flu A, Flu B and RSV, the new RTX plus control is ideal for use with multiplex assays. A dedicated SARS-CoV-2 control is also available.<br \/>\nComprising the full SARS CoV-2 genome, the control range is compatible for use with the majority of commercial and in-house assays. Whole pathogen controls are ideal for full-process validation, monitoring the testing process from extraction to amplification and detection, ensuring the ultimate quality assurance in laboratories.<br \/>\nAdditionally, the third-party nature of these controls ensures an independent, unbiased assessment of assay performance in-line with ISO 15189 regulatory requirements. Supplied in a liquid easy to use format, minimal preparation is required. A complementary negative control is also available delivering a complete testing package.<br \/>\nFor more information, visit: <link https:\/\/www.randox.com\/sars-cov-2-molecular-control\/ _blank>https:\/\/www.randox.com\/sars-cov-2-molecular-control\/<\/link>\n<!--more--><br \/>\n<strong>Supplier:<\/strong> [No title]<br \/>\n<strong>Website:<\/strong> <a href=\"https:\/\/www.randox.com\/sars-cov-2-molecular-control\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.randox.com\/sars-cov-2-molecular-control\/<\/a><\/p>\n<p><a class=\"avia-button avia-color-theme-color\" href=\"mailto:\">Mail the supplier<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Qnostics, a world leading manufacturer of QC solutions for molecular infectious disease testing, has developed a range of products designed to support the validation, verification and performance monitoring of molecular assays used in the testing of SARS-CoV-2. Conveniently combining SARS-CoV-2, Flu A, Flu B and RSV, the new RTX plus control is ideal for use [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/13233"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=13233"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/13233\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=13233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=13233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=13233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}